Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,915
Closed -$485K 200
2022
Q2
$485K Buy
8,915
+996
+13% +$55K 0.21% 103
2022
Q1
$431K Buy
7,919
+460
+6% +$25K 0.2% 106
2021
Q4
$411K Hold
7,459
0.2% 101
2021
Q3
$356K Buy
7,459
+80
+1% +$4.02K 0.19% 101
2021
Q2
$367K Hold
7,379
0.2% 98
2021
Q1
$329K Buy
7,379
+80
+1% +$3.63K 0.2% 97
2020
Q4
$336K Buy
7,299
+6,159
+540% +$283K 0.22% 95
2020
Q3
$54K Buy
+1,140
New +$57.1K 0.04% 215

Other funds holding GSK

Jeppson Wealth Management's GSK Position: Q3 2022 in Review

Jeppson Wealth Management sold out of GSK (GSK) in Q3 2022, closing a stake of 8,915 shares — an estimated $485K sold.

Jeppson Wealth Management first reported a position in GSK in Q3 2020 and held it in 8 quarters. The position peaked at $485K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Jeppson Wealth Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Jeppson Wealth Management sold 8,915 GSK shares in Q3 2022, an estimated $485K.
  • Jeppson Wealth Management first reported a position in GSK in Q3 2020 and held it in 8 quarters.
  • Jeppson Wealth Management's GSK position peaked at $485K in Q2 2022.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Jeppson Wealth Management's 13F filing for Q3 2022, filed 20 Oct 2022.